Results 191 to 200 of about 1,850,678 (233)
Some of the next articles are maybe not open access.

Systemic sclerosis or scleroderma

Independent Nurse, 2007
This article provides a definition of systemic sclerosis orscleroderma and its epidemiology
Josip Car, Aziz Sheikh
openaire   +2 more sources

Juvenile systemic scleroderma

Current Rheumatology Reports, 2001
Systemic scleroderma in children is very rare and is considered similar to adult-onset disease. In adults, new etiopathogenetic and therapeutic approaches have emerged in recent years. For instance, it has been shown that microchimerism could play a role in disease pathogenesis and that immunoablation followed by stem cell rescue could be of potential ...
openaire   +3 more sources

Systemic scleroderma: a spatiotemporal clustering

Internal Medicine Journal, 2005
AbstractBackground and aims: The aetiology of systemic scleroderma remains poorly understood. Twin studies suggest a low genetic input. Of the incriminated environmental agents, silica and vinyl chloride monomer exposure appear the most convincing. Spatiotemporal clustering has been demonstrated only three times previously.
Englert, H   +7 more
openaire   +3 more sources

Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindred.

Arthritis & Rheumatism, 1981
A kindred is reported which contains 3 siblings with scleroderma, 2 siblings with Raynaud's phenomenon, and 2 first-degree relatives with histories suggestive of connective tissue syndromes. Studies of microvascular morphology and flow, serum endothelial
W. B. Sheldon   +7 more
semanticscholar   +1 more source

Systemic scleroderma

Journal of the American Academy of Dermatology, 1988
Systemic scleroderma is a generalized disease of connective tissue involving mainly the skin, the gastrointestinal tract, the lungs, the heart, and the kidneys. It can be present in different forms, of which acroscleroderma, with limited cutaneous and extracutaneous involvement, and diffuse scleroderma within a more rapid progression are most ...
Michael Meurer, Thomas Krieg
openaire   +3 more sources

Radiological features of mixed connective tissue disease and scleroderma--systemic lupus erythematosus overlap.

Radiology, 1976
The radiological, clinical, and laboratory features found in seven patients with scleroderma-SLE overlap, including three with mixed connective tissue disease (MCTD), are described. There were no distinctive roentgenographic features which differentiated
Terry M. Sliver   +3 more
semanticscholar   +1 more source

Progressive Systemic Sclerosis (Scleroderma)

New England Journal of Medicine, 1953
THE skin manifestations of scleroderma have long been recognized and adequately described. These features are usually identified readily, particularly in the later phases of the disease when the spectacular, hardened, bound-down, wrinkleless appearance of the skin is so characteristic as to supply a descriptive name for the illness. This term refers to
Theodore B. Bayles   +2 more
openaire   +4 more sources

Scleroderma-Inducing Glycosaminoglycan in the Urine of Patients with Systemic Scleroderma

Dermatology, 1978
A glycosaminoglycan with scleroderma-inducing effect was isolated and partially purified from the urine of patients with systemic scleroderma. The glycosaminoglycan was an N-sulfated glycosaminoglycuronan and its high total sulfate and 2,5-anhydromannose contents suggest that the glycosaminoglycan is a degradation product of heparin or polysulfated ...
Hidekazu Ishikawa   +3 more
openaire   +3 more sources

Mortality in Systemic Sclerosis (Scleroderma)

QJM: An International Journal of Medicine, 1992
Two hundred and thirty-seven patients with systemic sclerosis were followed prospectively in a scleroderma clinic. The overall 3, 6, and 9-year survival rates were 86, 76 and 61 per cent respectively. Renal, cardiac and pulmonary disease, and older age at enrollment were adverse prognostic factors associated with reduced survival.
M Aubrey   +9 more
openaire   +3 more sources

HLA and autoimmunity in scleroderma (systemic sclerosis).

International Reviews of Immunology, 1995
Scleroderma or systemic sclerosis (SSc) has been associated with certain class II antigens of the major histocompatibility complex (MHC), including HLA-DR1, DR2, DR3, DR5, and DR52.
F. Arnett
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy